|
All cancer patients
|
207 (100 %)
|
15
|
72
|
130
|
|
Lung cancer
|
37 (17.9 %)
|
19.5
|
77.5
|
127
|
|
Colorectal cancer
|
26 (12.6 %)
|
11
|
56
|
110
|
|
Hematopoietic tissue cancer
|
21 (10.1 %)
|
19
|
85
|
278
|
|
Pancreatic cancer
|
19 (9.2 %)
|
7
|
22
|
51
|
|
Oesophagus, stomach and small intestine cancer
|
17 (8.2 %)
|
32.5
|
88
|
130
|
|
Breast cancer
|
13 (6.3 %)
|
8
|
24
|
35
|
|
Liver and biliary system cancer
|
11 (5.3 %)
|
7
|
49
|
80
|
|
Kidney cancer
|
11 (5.3 %)
|
35
|
69
|
168
|
|
Metastasis
|
11 (5.3 %)
|
51
|
100
|
345
|
|
Prostate cancer
|
10 (4.8 %)
|
53
|
131.5
|
357
|
|
Brain cancer
|
5 (2.4 %)
|
21
|
21
|
52
|
|
Cervix, ovarian and uterus cancer
|
4 (1.9 %)
|
29
|
69.5
|
96
|
|
Malignant melanoma
|
4 (1.9 %)
|
12.5
|
79
|
135
|
|
Soft tissue cancer
|
4 (1.9 %)
|
36.5
|
79
|
99
|
|
Unspecified cancer
|
4 (1.9 %)
|
123
|
365
|
365
|
|
Lip, oral and pharynx cancer
|
2 (1.0 %)
|
9
|
9
|
9
|
|
Thyroid cancer
|
2 (1.0 %)
|
6
|
8
|
8
|
|
Other cancers*
|
6 (2.9 %)
|
34
|
74
|
108
|
